BRPI0821002A2 - Compostos e métodos para o tratamento de câncer - Google Patents

Compostos e métodos para o tratamento de câncer

Info

Publication number
BRPI0821002A2
BRPI0821002A2 BRPI0821002-0A BRPI0821002A BRPI0821002A2 BR PI0821002 A2 BRPI0821002 A2 BR PI0821002A2 BR PI0821002 A BRPI0821002 A BR PI0821002A BR PI0821002 A2 BRPI0821002 A2 BR PI0821002A2
Authority
BR
Brazil
Prior art keywords
methods
cancer treatment
treatment compounds
compounds
cancer
Prior art date
Application number
BRPI0821002-0A
Other languages
English (en)
Inventor
John C Amedio Jr
Frank Walter Waligora
Original Assignee
Ziopharm Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziopharm Oncology Inc filed Critical Ziopharm Oncology Inc
Publication of BRPI0821002A2 publication Critical patent/BRPI0821002A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/72—Aliphatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0821002-0A 2007-12-12 2008-12-12 Compostos e métodos para o tratamento de câncer BRPI0821002A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US737107P 2007-12-12 2007-12-12
PCT/US2008/013620 WO2009075870A1 (en) 2007-12-12 2008-12-12 Compounds and methods for the treatment of cancer

Publications (1)

Publication Number Publication Date
BRPI0821002A2 true BRPI0821002A2 (pt) 2015-06-16

Family

ID=40755796

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821002-0A BRPI0821002A2 (pt) 2007-12-12 2008-12-12 Compostos e métodos para o tratamento de câncer

Country Status (12)

Country Link
US (1) US20100331403A1 (pt)
EP (1) EP2231684A4 (pt)
JP (2) JP5600597B2 (pt)
KR (1) KR20100097679A (pt)
CN (2) CN104592302A (pt)
AU (1) AU2008335705A1 (pt)
BR (1) BRPI0821002A2 (pt)
CA (1) CA2705467A1 (pt)
HK (1) HK1209754A1 (pt)
IL (1) IL205339A0 (pt)
SG (1) SG186599A1 (pt)
WO (1) WO2009075870A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202001669UA (en) * 2017-10-17 2020-03-30 Univ Wollongong Anti-cancer agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2349729A (en) * 1940-08-24 1944-05-23 Parke Davis & Co Therapeutic arsenic preparation
JP2001519366A (ja) * 1997-10-15 2001-10-23 ポーラクス バイオファーマシュティカルズ，インコーポレーテッド ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
IL136051A0 (en) * 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
CN1233476A (zh) * 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
EP1328253B1 (en) * 2000-04-26 2006-03-22 Oregon Health Sciences University Administration of a thiol-based chemoprotectant compound
US6911471B2 (en) * 2002-01-07 2005-06-28 The Texas A&M University System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TWI411431B (zh) * 2004-07-16 2013-10-11 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
ES2532666T3 (es) * 2005-07-29 2015-03-30 Solasia Pharma K.K. Compuestos y métodos para el tratamiento del cáncer
WO2007082104A2 (en) * 2006-01-13 2007-07-19 The Texas A & M University System Compounds and methods for the treatment of cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals

Also Published As

Publication number Publication date
EP2231684A4 (en) 2011-09-07
WO2009075870A1 (en) 2009-06-18
CA2705467A1 (en) 2009-06-18
JP2011506443A (ja) 2011-03-03
CN101874034A (zh) 2010-10-27
JP2015063514A (ja) 2015-04-09
HK1209754A1 (en) 2016-04-08
IL205339A0 (en) 2010-12-30
AU2008335705A1 (en) 2009-06-18
SG186599A1 (en) 2013-01-30
JP5600597B2 (ja) 2014-10-01
KR20100097679A (ko) 2010-09-03
CN104592302A (zh) 2015-05-06
WO2009075870A9 (en) 2009-10-29
US20100331403A1 (en) 2010-12-30
EP2231684A1 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BRPI0810206A2 (pt) Método de tratar câncer
BRPI0818320A2 (pt) composição para tratamento de câncer de próstata (pca)
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0821660A2 (pt) Combinações de agentes terapêuticos para tratamento de câncer
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
DK2121139T3 (da) Formulations for cancer treatment
IL197217B (en) Novel anti-cd38 antibodies for the treatment of cancer
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0819076A2 (pt) aparelho para tratamento de água
BRPI0810525A2 (pt) Composições e métodos para a profilaxia e tratamento de dependência química
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BR112012004281A2 (pt) uso de metformina tratamento e prevenção de câncer
BRPI0909016A2 (pt) anticorpos úteis para o tratamento do câncer
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
DK2173831T3 (da) Brøndbehandling
BRPI0813364A2 (pt) Métodos de diagnóstico e tratamento de câncer.
DE502008000740D1 (de) Rollosystem

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.